Wealth Enhancement Advisory Services, LLC Heron Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 37,128 shares of HRTX stock, worth $49,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,128
Previous 35,616
4.25%
Holding current value
$49,751
Previous $78,000
2.56%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HRTX
# of Institutions
185Shares Held
130MCall Options Held
1.56MPut Options Held
27.1K-
Rubric Capital Management LP New York, NY26.7MShares$35.8 Million1.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.47MShares$11.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$11.2 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$10.5 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$9.36 Million24.86% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $159M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...